Form 4: Cognex Director Dianne M. Parrotte Reports Stock Transactions
SEC Form 4
Director Dianne M. Parrotte reports multiple transactions involving Cognex Corp (CGNX) common stock and restricted stock units from February 20, 2025, to February 22, 2025.
Summary
- Dianne M. Parrotte, a director of Cognex Corp (CGNX), filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve the acquisition and disposal of common stock through the vesting of restricted stock units.
- On February 20, 2025, 6,973 shares of common stock were acquired through the vesting of restricted stock units.
- On February 21, 2025, 1,747 shares of common stock were acquired through the vesting of restricted stock units.
- On February 22, 2025, 2,134 shares of common stock were acquired through the vesting of restricted stock units.
- Following these transactions, Parrotte directly owns 22,194 shares of Cognex common stock.
- Parrotte also holds derivative securities, including non-qualified stock options and restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, with no inherently positive or negative implications.
Positives
- The vesting of restricted stock units indicates that performance milestones have been met.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions have a minimal impact on stakeholders as they represent a small portion of the overall outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/02/2019 | Date exercisable for Non-Qualified Stock Option (right to buy) at $45.06 |
| 02/19/2020 | Date exercisable for Non-Qualified Stock Option (right to buy) at $51.49 |
| 02/18/2021 | Date exercisable for Non-Qualified Stock Option (right to buy) at $50.94 |
| 02/22/2022 | First anniversary of the grant date for 2,134 restricted stock units. |
| 02/21/2023 | First anniversary of the grant date for 1,747 restricted stock units. |
| 02/20/2024 | First anniversary of the grant date for 6,973 restricted stock units. |
| 02/18/2026 | Date exercisable for Restricted Stock Unit |
| 05/02/2028 | Expiration date for Non-Qualified Stock Option (right to buy) at $45.06 |
| 02/19/2029 | Expiration date for Non-Qualified Stock Option (right to buy) at $51.49 |
| 02/18/2030 | Expiration date for Non-Qualified Stock Option (right to buy) at $50.94 |
| 02/20/2025 | Transaction date for acquisition of 6,973 shares of common stock and vesting of 6,973 restricted stock units. |
| 02/21/2025 | Transaction date for acquisition of 1,747 shares of common stock and vesting of 1,747 restricted stock units. |
| 02/22/2025 | Transaction date for acquisition of 2,134 shares of common stock and vesting of 2,134 restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.